Insider Transactions in Q2 2021 at Chemo Centryx, Inc. (CCXI)
Insider Transaction List (Q2 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
May 21
2021
|
Rita Jain EVP, Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,660
+16.92%
|
-
|
|
May 21
2021
|
James L Tyree Director |
SELL
Open market or private sale
|
Direct |
2,454
-13.84%
|
$22,086
$9.76 P/Share
|
|
May 21
2021
|
James L Tyree Director |
BUY
Exercise of conversion of derivative security
|
Direct |
4,660
+20.81%
|
-
|
|
May 21
2021
|
Geoffrey M. Parker Director |
BUY
Exercise of conversion of derivative security
|
Indirect |
4,660
+25.87%
|
-
|
|
May 20
2021
|
Thomas A. Edwards Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,726
+5.71%
|
-
|
|
May 20
2021
|
Joseph M Feczko Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,726
+6.53%
|
-
|
|
May 07
2021
|
Tausif Butt EVP, Chief Operating Officer |
BUY
Open market or private purchase
|
Direct |
10,870
+50.0%
|
$119,570
$11.06 P/Share
|